CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
Clinical trial NCT05896137 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05896137
- Sponsor
- Cascade Pharmaceuticals, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-07
- Primary completion
- 2025-11-14
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.